Crossmark

Octreotide (somatostatin analog) attenuates cardiac ischemia/reperfusion injury via activating nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway in rat model of hyperthyroidism

Crossref DOI link: https://doi.org/10.1186/s43094-020-00127-w

Published Online: 2020-10-21

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gomaa, Randa Salah http://orcid.org/0000-0001-5463-084X
Mahmoud, Nevertyty Mohamed

Mohammed, Nourelhuda Abdelaziz
License Information

Text and Data Mining valid from 2020-10-21

Version of Record valid from 2020-10-21
More Information

Article History

Received: 5 May 2020

Accepted: 12 October 2020

First Online: 21 October 2020

Ethics approval and consent to participate

: All experimental procedures and protocols were following the guide for the care and use of laboratory animals (8th edition, National Academies Press) and have been reviewed and approved by Zagazig University institutional animal care unit committee (ZU-IACUC; Sharkia; Egypt) with approval number: ZU-IACUC/3/F/38/2019.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below